232 related articles for article (PubMed ID: 18694759)
21. Global architecture of human poly(A)-specific ribonuclease by atomic force microscopy in liquid and dynamic light scattering.
Niedzwiecka A; Lekka M; Nilsson P; Virtanen A
Biophys Chem; 2011 Oct; 158(2-3):141-9. PubMed ID: 21741754
[TBL] [Abstract][Full Text] [Related]
22. Structural basis of m7GpppG binding to the nuclear cap-binding protein complex.
Calero G; Wilson KF; Ly T; Rios-Steiner JL; Clardy JC; Cerione RA
Nat Struct Biol; 2002 Dec; 9(12):912-7. PubMed ID: 12434151
[TBL] [Abstract][Full Text] [Related]
23. Competitive inhibition of human poly(A)-specific ribonuclease (PARN) by synthetic fluoro-pyranosyl nucleosides.
Balatsos NA; Vlachakis D; Maragozidis P; Manta S; Anastasakis D; Kyritsis A; Vlassi M; Komiotis D; Stathopoulos C
Biochemistry; 2009 Jul; 48(26):6044-51. PubMed ID: 19472977
[TBL] [Abstract][Full Text] [Related]
24. The crystal structure of mouse Nup35 reveals atypical RNP motifs and novel homodimerization of the RRM domain.
Handa N; Kukimoto-Niino M; Akasaka R; Kishishita S; Murayama K; Terada T; Inoue M; Kigawa T; Kose S; Imamoto N; Tanaka A; Hayashizaki Y; Shirouzu M; Yokoyama S
J Mol Biol; 2006 Oct; 363(1):114-24. PubMed ID: 16962612
[TBL] [Abstract][Full Text] [Related]
25. RRM proteins interacting with the cap region of topoisomerase I.
Trzcińska-Daneluti AM; Górecki A; Czubaty A; Kowalska-Loth B; Girstun A; Murawska M; Lesyng B; Staroń K
J Mol Biol; 2007 Jun; 369(4):1098-112. PubMed ID: 17481653
[TBL] [Abstract][Full Text] [Related]
26. Messenger RNA turnover in eukaryotes: pathways and enzymes.
Meyer S; Temme C; Wahle E
Crit Rev Biochem Mol Biol; 2004; 39(4):197-216. PubMed ID: 15596551
[TBL] [Abstract][Full Text] [Related]
27. Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus.
Bollati M; Milani M; Mastrangelo E; Ricagno S; Tedeschi G; Nonnis S; Decroly E; Selisko B; de Lamballerie X; Coutard B; Canard B; Bolognesi M
J Mol Biol; 2009 Jan; 385(1):140-52. PubMed ID: 18976670
[TBL] [Abstract][Full Text] [Related]
28. Stacking efficiency and flexibility analysis of aromatic amino acids in cap-binding proteins.
Worch R; Stolarski R
Proteins; 2008 Jun; 71(4):2026-37. PubMed ID: 18186485
[TBL] [Abstract][Full Text] [Related]
29. Biophysical approach to studies of cap-eIF4E interaction by synthetic cap analogs.
Niedzwiecka A; Stepinski J; Antosiewicz JM; Darzynkiewicz E; Stolarski R
Methods Enzymol; 2007; 430():209-45. PubMed ID: 17913640
[TBL] [Abstract][Full Text] [Related]
30. Analysis of decapping scavenger cap complex using modified cap analogs reveals molecular determinants for efficient cap binding.
Wypijewska del Nogal A; Surleac MD; Kowalska J; Lukaszewicz M; Jemielity J; Bisaillon M; Darzynkiewicz E; Milac AL; Bojarska E
FEBS J; 2013 Dec; 280(24):6508-27. PubMed ID: 24119043
[TBL] [Abstract][Full Text] [Related]
31. Large-scale induced fit recognition of an m(7)GpppG cap analogue by the human nuclear cap-binding complex.
Mazza C; Segref A; Mattaj IW; Cusack S
EMBO J; 2002 Oct; 21(20):5548-57. PubMed ID: 12374755
[TBL] [Abstract][Full Text] [Related]
32. Dinucleotide cap analogue affinity resins for purification of proteins that specifically recognize the 5' end of mRNA.
Jankowska-Anyszka M; Piecyk K
Bioorg Med Chem Lett; 2011 Oct; 21(20):6131-4. PubMed ID: 21889340
[TBL] [Abstract][Full Text] [Related]
33. Serum-deprivation stimulates cap-binding by PARN at the expense of eIF4E, consistent with the observed decrease in mRNA stability.
Seal R; Temperley R; Wilusz J; Lightowlers RN; Chrzanowska-Lightowlers ZM
Nucleic Acids Res; 2005; 33(1):376-87. PubMed ID: 15653638
[TBL] [Abstract][Full Text] [Related]
34. Cap binding and immune evasion revealed by Lassa nucleoprotein structure.
Qi X; Lan S; Wang W; Schelde LM; Dong H; Wallat GD; Ly H; Liang Y; Dong C
Nature; 2010 Dec; 468(7325):779-83. PubMed ID: 21085117
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of TB-RBP, a novel RNA-binding and regulating protein.
Pascal JM; Hart PJ; Hecht NB; Robertus JD
J Mol Biol; 2002 Jun; 319(5):1049-57. PubMed ID: 12079346
[TBL] [Abstract][Full Text] [Related]
36. Diverse role of three tyrosines in binding of the RNA 5' cap to the human nuclear cap binding complex.
Worch R; Jankowska-Anyszka M; Niedzwiecka A; Stepinski J; Mazza C; Darzynkiewicz E; Cusack S; Stolarski R
J Mol Biol; 2009 Jan; 385(2):618-27. PubMed ID: 19026660
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability.
Grudzien-Nogalska E; Stepinski J; Jemielity J; Zuberek J; Stolarski R; Rhoads RE; Darzynkiewicz E
Methods Enzymol; 2007; 431():203-27. PubMed ID: 17923237
[TBL] [Abstract][Full Text] [Related]
38. Unravelling the dynamics of RNA degradation by ribonuclease II and its RNA-bound complex.
Frazão C; McVey CE; Amblar M; Barbas A; Vonrhein C; Arraiano CM; Carrondo MA
Nature; 2006 Sep; 443(7107):110-4. PubMed ID: 16957732
[TBL] [Abstract][Full Text] [Related]
39. Interaction between a poly(A)-specific ribonuclease and the 5' cap influences mRNA deadenylation rates in vitro.
Gao M; Fritz DT; Ford LP; Wilusz J
Mol Cell; 2000 Mar; 5(3):479-88. PubMed ID: 10882133
[TBL] [Abstract][Full Text] [Related]
40. Crystallographic and mass spectrometric characterisation of eIF4E with N7-alkylated cap derivatives.
Brown CJ; McNae I; Fischer PM; Walkinshaw MD
J Mol Biol; 2007 Sep; 372(1):7-15. PubMed ID: 17631896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
